1. Home
  2. RAPT vs RVSB Comparison

RAPT vs RVSB Comparison

Compare RAPT & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • RVSB
  • Stock Information
  • Founded
  • RAPT 2015
  • RVSB 1923
  • Country
  • RAPT United States
  • RVSB United States
  • Employees
  • RAPT N/A
  • RVSB N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • RVSB Savings Institutions
  • Sector
  • RAPT Health Care
  • RVSB Finance
  • Exchange
  • RAPT Nasdaq
  • RVSB Nasdaq
  • Market Cap
  • RAPT 117.5M
  • RVSB 124.0M
  • IPO Year
  • RAPT 2019
  • RVSB 1993
  • Fundamental
  • Price
  • RAPT $0.89
  • RVSB $5.56
  • Analyst Decision
  • RAPT Buy
  • RVSB Buy
  • Analyst Count
  • RAPT 5
  • RVSB 1
  • Target Price
  • RAPT $5.25
  • RVSB $7.00
  • AVG Volume (30 Days)
  • RAPT 1.1M
  • RVSB 259.2K
  • Earning Date
  • RAPT 05-08-2025
  • RVSB 07-24-2025
  • Dividend Yield
  • RAPT N/A
  • RVSB 1.46%
  • EPS Growth
  • RAPT N/A
  • RVSB 27.97
  • EPS
  • RAPT N/A
  • RVSB 0.23
  • Revenue
  • RAPT N/A
  • RVSB $50,500,000.00
  • Revenue This Year
  • RAPT N/A
  • RVSB $12.10
  • Revenue Next Year
  • RAPT N/A
  • RVSB $11.53
  • P/E Ratio
  • RAPT N/A
  • RVSB $24.17
  • Revenue Growth
  • RAPT N/A
  • RVSB 4.49
  • 52 Week Low
  • RAPT $0.71
  • RVSB $3.30
  • 52 Week High
  • RAPT $4.60
  • RVSB $6.59
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 48.13
  • RVSB 31.37
  • Support Level
  • RAPT $0.81
  • RVSB $5.75
  • Resistance Level
  • RAPT $1.27
  • RVSB $6.08
  • Average True Range (ATR)
  • RAPT 0.14
  • RVSB 0.24
  • MACD
  • RAPT 0.01
  • RVSB -0.08
  • Stochastic Oscillator
  • RAPT 31.55
  • RVSB 9.64

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

Share on Social Networks: